Company Filing History:
1 out of 42 
1 out of 113 Years Active: 2018
Title: The Innovative Work of Inventor Ianina Valenta in Animal Obesity Treatment
Introduction: Ianina Valenta, an accomplished inventor based in La Jolla, California, is renowned for her significant contribution to veterinary medicine through her innovative patent. With a focus on treating obesity in companion animals, she has brought forth groundbreaking methods that leverage modified canine leptin polypeptides.
Latest Patents: Ianina Valenta holds a patent for a method of treating obesity in companion animals which involves administering a modified canine leptin polypeptide. This innovative approach includes polyethylene glycol (PEG) modified canine leptin polypeptides, wherein the PEG moiety is covalently attached to a para-acetyl-phenylalanine (pAF) residue of the polypeptide. The related compositions and methods aim to effectively treat companion animal obesity and other leptin-related disorders.
Career Highlights: Throughout her career, Ianina has made significant strides in the field of animal health. She has worked with prominent companies such as Elanco US Inc. and Ambrx, Inc., where she honed her skills and expanded her knowledge in developing treatments for veterinary challenges.
Collaborations: Ianina Valenta has collaborated with several esteemed professionals in her field, including her notable coworkers Michael Bledsoe and Peter Connor Canning. These partnerships have further driven her innovation and impacted the advancement of treatments in veterinary medicine.
Conclusion: Ianina Valenta’s pioneering work in the treatment of companion animal obesity through the use of modified canine leptin polypeptides highlights her role as a leading inventor in the field. Her dedication to improving animal health continues to inspire advancements in veterinary research and treatment methodologies.